RAPEZZI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 17.776
EU - Europa 12.282
AS - Asia 10.843
AF - Africa 913
SA - Sud America 677
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 6
Totale 42.527
Nazione #
US - Stati Uniti d'America 17.630
SG - Singapore 3.554
GB - Regno Unito 3.130
CN - Cina 2.871
VN - Vietnam 2.338
IT - Italia 2.305
DE - Germania 1.689
SE - Svezia 1.439
HK - Hong Kong 879
RU - Federazione Russa 739
IN - India 635
UA - Ucraina 613
FR - Francia 554
BR - Brasile 502
IE - Irlanda 479
NL - Olanda 337
ZA - Sudafrica 268
EE - Estonia 260
CI - Costa d'Avorio 249
TG - Togo 215
FI - Finlandia 179
BG - Bulgaria 128
JP - Giappone 127
JO - Giordania 111
KR - Corea 106
CA - Canada 103
BE - Belgio 94
AR - Argentina 86
CH - Svizzera 83
SC - Seychelles 79
NG - Nigeria 70
PL - Polonia 65
IR - Iran 53
GR - Grecia 40
ID - Indonesia 38
AT - Austria 36
EC - Ecuador 26
MX - Messico 26
BD - Bangladesh 25
AU - Australia 23
CL - Cile 20
LT - Lituania 17
RO - Romania 16
UZ - Uzbekistan 16
ES - Italia 14
LB - Libano 13
CO - Colombia 12
MY - Malesia 12
PY - Paraguay 11
HR - Croazia 10
MA - Marocco 10
TR - Turchia 10
PE - Perù 9
EG - Egitto 8
CZ - Repubblica Ceca 7
IQ - Iraq 7
MD - Moldavia 7
AL - Albania 6
DK - Danimarca 6
HN - Honduras 6
HU - Ungheria 6
NZ - Nuova Zelanda 6
PK - Pakistan 6
VE - Venezuela 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AE - Emirati Arabi Uniti 5
GE - Georgia 5
NO - Norvegia 5
AZ - Azerbaigian 4
IL - Israele 4
LU - Lussemburgo 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
PT - Portogallo 3
AM - Armenia 2
DZ - Algeria 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PH - Filippine 2
SA - Arabia Saudita 2
SM - San Marino 2
SN - Senegal 2
TL - Timor Orientale 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
Totale 42.512
Città #
Southend 2.757
Singapore 2.356
Fairfield 2.123
Ashburn 1.918
Chandler 1.358
Woodbridge 1.081
Houston 977
Seattle 931
Wilmington 889
Hong Kong 871
Dong Ket 771
Cambridge 770
Ann Arbor 765
Santa Clara 750
Princeton 668
Dublin 478
Beijing 457
Boardman 431
Ho Chi Minh City 346
Jacksonville 318
Westminster 298
Nanjing 281
Padova 277
Hanoi 262
Hefei 262
Bologna 261
Abidjan 249
Los Angeles 234
Lomé 215
Berlin 200
New York 184
Saint Petersburg 167
Bremen 156
Munich 148
Milan 147
Buffalo 130
Turin 129
Jinan 126
Sofia 125
Rome 121
Shenyang 120
Helsinki 118
Tokyo 112
Amman 109
San Diego 109
Redondo Beach 103
Dearborn 98
Nanchang 95
Seoul 94
Brussels 92
Changsha 91
Hebei 87
Frankfurt am Main 79
Dallas 78
São Paulo 75
Tianjin 75
Abeokuta 69
Jiaxing 63
Bern 62
Guangzhou 62
Medford 62
Mülheim 61
Chicago 58
Turku 57
Zhengzhou 55
Florence 48
Des Moines 45
Falkenstein 45
Toronto 45
Haikou 44
London 44
Shanghai 44
Norwalk 43
Yubileyny 43
Phoenix 42
Naples 41
Falls Church 40
Redwood City 40
Warsaw 40
Redmond 39
Hangzhou 38
Olalla 38
Haiphong 33
San Francisco 33
Ningbo 31
Taiyuan 31
Mahé 30
Paris 30
Da Nang 28
Taizhou 28
The Dalles 28
Brescia 27
Orem 27
Verona 27
Bengaluru 26
Hải Dương 26
Kuban 26
Kunming 26
Lanzhou 26
Nuremberg 25
Totale 28.298
Nome #
Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM) 585
ATEROMASIA DELL'ARCO AORTICO COME FATTORE PREDITTIVO DI EMBOLIA CEREBRALE DURANTE LE PROCEDURE DI STENTING CAROTIDEO. STUDIO PROSPETTICO CON ECOCARDIODOPPLER TRANSESOFAGEO A DIFFUSIONE E RISONANZA MAGNETICA 498
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy 356
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis 342
Ventricular remodeling in Loeffler endocarditis: Implications for therapeutic decision making. 277
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 273
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 255
Effects of myocardial fibrosis assessed by MRI on dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a retrospective database analysis. 242
Usefulness and limitations of (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. 239
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 234
Sempre oscura mi fu quest'aVR. L'insospettabile ricchezza di una derivazione dimenticata 228
Parodoxical contributions of non-compacted and compacted segments to global left ventricular dysfunction in isolated left ventriculat noncompaction 219
Atrial fibrillation in amyloidotic cardiomyopathy: Prevalence, incidence, risk factors and prognostic role 219
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 215
Noninvasive etiologic diagnosis of cardiac amyloidosis using (99m)tc-3,3-diphosphono-1,2-propanodicarboxylic Acid scintigraphy. 211
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 208
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 207
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths 205
Amiloidosi ereditaria da mutazione della transtiretina: caratterizzazione dei casi con interessamento cardiaco esclusivo o prevalente 202
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy 201
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 200
Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT? 199
Carotid revascularization in patients with ongoing oral anticoagulant therapy: the advantages of stent placement. 197
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 195
Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. 192
The elusive link between aortic wall histology and echocardiographic anatomy in bicuspid aortic valve: implications for prophylactic surgery 190
Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. 190
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 190
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 189
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy. 189
An unusual case of a congenital aorto-left atrial tunnel. 187
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 186
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 185
Noninvasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. 184
Risk Factors for diagnostic delay in acute aortic dissection. 182
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 182
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 181
Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography. 180
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation 180
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 178
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 178
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 176
Cardiac involvement in hereditary-transthyretin related amyloidosis. 176
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 176
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 174
Cardiac amyloidosis: the great pretender 174
Accuracy of non-invasive techniques for diagnosis of coronary artery disease and prediction of cardiac events in patients with left bundle branch block: a meta-analysis. 174
Different types of cardiomyopathy associated with isolated ventricular noncompaction 173
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 173
Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy. 171
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis. 171
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 169
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 167
Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis 167
Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis∗ 166
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 166
Age and heart transplantation: results from a heart failure management unit. 166
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 165
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 165
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 165
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 164
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. 164
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure 163
Inferior Q waves in apparently healthy subjects: Should we take a deep breath? An electrocardiographic, echocardiographic and cardiac magnetic resonance study 162
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy 162
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 162
Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy 162
Genotype-phenotype correlations in amyloidotic cardiomyopathy. 161
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report 161
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction 160
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 160
The residual risk of cerebral embolism after carotid stenting: the complex interplay between stent coverage and aortic arch atherosclerosis. 159
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis 159
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 159
Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. 159
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 159
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 158
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 157
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 157
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 156
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 156
Brain microbleeds 12 Years after orthotopic liver transplantation in Val30Met amyloidosis 156
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 155
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 155
Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. 154
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis. 154
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 154
The empowerment of translational research: lessons from laminopathies. 154
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy 154
Gadolinium enhancement cardiac magnetic resonance in cardiac amyloidosis: clinical, pathophysiologic an hystologic correlations. 153
Transesophageal echocardiography-guided algorithm for stent-graft implantation in aortic dissection 153
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 153
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 151
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 151
Frequency, determinants, and clinical relevance of acute coronary syndrome-like electrocardiographic findings in patients with acute aortic syndrome 151
Amyloidosis. Also a heart disease 150
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 150
Prenatal echographic recognition of hypertrophic cardiomyopathy leading to heart transplantation in the newborn. 149
Diagnosi e terapia in cardiologia : l'essenziale a portata di mano 149
Comparison of ventricular long-axis function in patients with cardiac amyloidosis versus idiopathic restrictive cardiomyopathy. 149
Totale 18.839
Categoria #
all - tutte 117.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.854 0 0 0 0 0 186 65 251 444 216 201 1.491
2021/20225.728 503 284 368 541 528 326 157 364 235 358 1.109 955
2022/20236.374 639 860 356 920 482 490 163 355 1.159 181 456 313
2023/20241.768 118 318 142 161 149 416 95 72 46 121 66 64
2024/20256.231 255 1.032 532 540 1.079 270 329 201 85 439 187 1.282
2025/20266.936 1.336 1.081 1.142 978 1.631 768 0 0 0 0 0 0
Totale 43.367